Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Clinical significance of papillary thyroid cancer risk loci identified by genome-wide association studies.

Wei WJ, Lu ZW, Wang Y, Zhu YX, Wang YL, Ji QH.

Cancer Genet. 2015 Mar;208(3):68-75. doi: 10.1016/j.cancergen.2015.01.004. Epub 2015 Jan 30.

PMID:
25746573
2.

Confirmation of papillary thyroid cancer susceptibility loci identified by genome-wide association studies of chromosomes 14q13, 9q22, 2q35 and 8p12 in a Chinese population.

Wang YL, Feng SH, Guo SC, Wei WJ, Li DS, Wang Y, Wang X, Wang ZY, Ma YY, Jin L, Ji QH, Wang JC.

J Med Genet. 2013 Oct;50(10):689-95. doi: 10.1136/jmedgenet-2013-101687. Epub 2013 Jul 11.

PMID:
23847140
3.

Papillary Thyroid Carcinoma: Association Between Germline DNA Variant Markers and Clinical Parameters.

Jendrzejewski J, Liyanarachchi S, Nagy R, Senter L, Wakely PE, Thomas A, Nabhan F, He H, Li W, Sworczak K, Ringel MD, Kirschner LS, de la Chapelle A.

Thyroid. 2016 Sep;26(9):1276-84. doi: 10.1089/thy.2015.0665. Epub 2016 Jul 22.

4.

Cumulative risk impact of five genetic variants associated with papillary thyroid carcinoma.

Liyanarachchi S, Wojcicka A, Li W, Czetwertynska M, Stachlewska E, Nagy R, Hoag K, Wen B, Ploski R, Ringel MD, Kozłowicz-Gudzinska I, Gierlikowski W, Jazdzewski K, He H, de la Chapelle A.

Thyroid. 2013 Dec;23(12):1532-40. doi: 10.1089/thy.2013.0102. Epub 2013 Aug 29.

5.

Are the SNPs of NKX2-1 associated with papillary thyroid carcinoma in the Han population of Northern China?

Ai L, Yu Y, Liu X, Wang C, Shi J, Sun H, Yu Q.

Front Med. 2014 Mar;8(1):113-7. doi: 10.1007/s11684-014-0310-x. Epub 2014 Jan 23.

PMID:
24452548
6.

Association between x-ray repair cross-complementing group 3 (XRCC3) genetic polymorphisms and papillary thyroid cancer susceptibility in a Chinese Han population.

Yuan K, Huo M, Sun Y, Wu H, Chen H, Wang Y, Fu R.

Tumour Biol. 2016 Jan;37(1):979-87. doi: 10.1007/s13277-015-3882-4. Epub 2015 Aug 12.

PMID:
26264616
7.

Replication and Meta-Analysis of Common Gene Mutations in TTF1 and TTF2 with Papillary Thyroid Cancer.

Gao Y, Chen F, Niu S, Lin S, Li S.

Medicine (Baltimore). 2015 Sep;94(36):e1246. doi: 10.1097/MD.0000000000001246.

8.

Association of the miR-149 Rs2292832 polymorphism with papillary thyroid cancer risk and clinicopathologic characteristics in a Chinese population.

Wei WJ, Lu ZW, Li DS, Wang Y, Zhu YX, Wang ZY, Wu Y, Wang YL, Ji QH.

Int J Mol Sci. 2014 Nov 14;15(11):20968-81. doi: 10.3390/ijms151120968.

9.

Clinical features of Hispanic thyroid cancer cases and the role of known genetic variants on disease risk.

Estrada-Florez AP, Bohórquez ME, Sahasrabudhe R, Prieto R, Lott P, Duque CS, Donado J, Mateus G, Bolaños F, Vélez A, Echeverry M, Carvajal-Carmona LG.

Medicine (Baltimore). 2016 Aug;95(32):e4148. doi: 10.1097/MD.0000000000004148.

10.

Association between single nucleotide polymorphisms of upstream transcription factor 1 (USF1) and susceptibility to papillary thyroid cancer.

Yuan Q, Bu Q, Li G, Zhang J, Cui T, Zhu R, Mu D.

Clin Endocrinol (Oxf). 2016 Apr;84(4):564-70. doi: 10.1111/cen.12832. Epub 2015 Aug 14.

PMID:
26052935
11.

Association of Toll-like receptor 2 polymorphisms with papillary thyroid cancer and clinicopathologic features in a Korean population.

Kim MK, Park SW, Kim SK, Park HJ, Eun YG, Kwon KH, Kim J.

J Korean Med Sci. 2012 Nov;27(11):1333-8. doi: 10.3346/jkms.2012.27.11.1333. Epub 2012 Oct 30.

12.

Polymorphisms in selected DNA repair genes and cell cycle regulating genes involved in the risk of papillary thyroid carcinoma.

Halkova T, Dvorakova S, Sykorova V, Vaclavikova E, Vcelak J, Vlcek P, Sykorova P, Kodetova D, Betka J, Lastuvka P, Bavor P, Hoch J, Katra R, Bendlova B.

Cancer Biomark. 2016 Jun 7;17(1):97-106. doi: 10.3233/CBM-160622.

PMID:
27314298
13.

Association between a promoter polymorphism (rs2192752, -1028A/C) of interleukin 1 receptor, type I (IL1R1) and location of papillary thyroid carcinoma in a Korean population.

Park SW, Kim MK, Kwon KH, Kim J.

Int J Immunogenet. 2012 Dec;39(6):501-7. doi: 10.1111/j.1744-313X.2012.01125.x. Epub 2012 May 18.

PMID:
22594576
14.

Associations between rs965513/rs944289 and papillary thyroid carcinoma risk: a meta-analysis.

Ai L, Liu X, Yao Y, Yu Y, Sun H, Yu Q.

Endocrine. 2014 Nov;47(2):428-34. doi: 10.1007/s12020-014-0256-4. Epub 2014 Apr 11.

PMID:
24723258
15.

Association between single-nucleotide polymorphisms of BRAF and papillary thyroid carcinoma in a Chinese population.

Zhang Q, Song F, Zheng H, Zhu X, Song F, Yao X, Zhang L, Chen K.

Thyroid. 2013 Jan;23(1):38-44. doi: 10.1089/thy.2012.0228.

16.

Selected single-nucleotide polymorphisms in FOXE1, SERPINA5, FTO, EVPL, TICAM1 and SCARB1 are associated with papillary and follicular thyroid cancer risk: replication study in a German population.

Sigurdson AJ, Brenner AV, Roach JA, Goudeva L, Müller JA, Nerlich K, Reiners C, Schwab R, Pfeiffer L, Waldenberger M, Braganza M, Xu L, Sturgis EM, Yeager M, Chanock SJ, Pfeiffer RM, Abend M, Port M.

Carcinogenesis. 2016 Jul;37(7):677-684. doi: 10.1093/carcin/bgw047. Epub 2016 Apr 28.

17.

Association between GWAS-Derived rs966423 Genetic Variant and Overall Mortality in Patients with Differentiated Thyroid Cancer.

Świerniak M, Wójcicka A, Czetwertyńska M, Długosińska J, Stachlewska E, Gierlikowski W, Kot A, Górnicka B, Koperski Ł, Bogdańska M, Wiechno W, Jażdżewski K.

Clin Cancer Res. 2016 Mar 1;22(5):1111-9. doi: 10.1158/1078-0432.CCR-15-1746. Epub 2015 Oct 21.

18.

Association between microRNA polymorphisms and papillary thyroid cancer susceptibility.

Dong G, Zhang R, Xu J, Guo Y.

Int J Clin Exp Pathol. 2015 Oct 1;8(10):13450-7. eCollection 2015.

19.

Pri-Mir-34b/C and Tp-53 Polymorphisms are Associated With The Susceptibility of Papillary Thyroid Carcinoma: A Case-Control Study.

Chen P, Sun R, Pu Y, Bai P, Yuan F, Liang Y, Zhou B, Wang Y, Sun Y, Zhu J, Zhang L, Gao L.

Medicine (Baltimore). 2015 Sep;94(38):e1536. doi: 10.1097/MD.0000000000001536.

20.

Multiple functional variants in long-range enhancer elements contribute to the risk of SNP rs965513 in thyroid cancer.

He H, Li W, Liyanarachchi S, Srinivas M, Wang Y, Akagi K, Wang Y, Wu D, Wang Q, Jin V, Symer DE, Shen R, Phay J, Nagy R, de la Chapelle A.

Proc Natl Acad Sci U S A. 2015 May 12;112(19):6128-33. doi: 10.1073/pnas.1506255112. Epub 2015 Apr 27.

Supplemental Content

Support Center